News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Rami Komrokji: All high risk MDS patients should be considered for transplant
Photo from moffitt.org
Sep 6, 2023, 17:03

Rami Komrokji: All high risk MDS patients should be considered for transplant

Hem-Onc Fellows Network shared on Twitter (X):

“Dr. Rami Komrokji from Moffitt Cancer Center presenting updates on high risk MDS and how HSCT is the only curative treatment available.

✍️ All high risk MDS patients should be considered for transplant!”

Rami Komrokji: All high risk MDS patients should be considered for transplant

Rami Komrokji: All high risk MDS patients should be considered for transplant

Source: Hem-Onc Fellows Network / Twitter (X)

Hem-Onc Fellows Network hemonc HSCT MDS OncoDaily Oncology Rami Komrokji SOHO SOHO2023 SOHO23
Special Coverage
Blog
Sep 1, 2024, 09:23
Estela Rodriguez: The Inaugural class of Sylvester Comprehensive Cancer Center Emerging Leaders Program
Insight
Sep 1, 2024, 09:17
Geriatric assessment in oncology by Allison Magnuson et al.
Insight
Sep 1, 2024, 09:14
Power Of Metals Gold, Silver, and Copper in Our Daily Lives and Cancer Treatment - The Babak Lab
Insight
Sep 1, 2024, 09:07
Springboard Enterprises's 2024 Healthcare and Technology Council
Insight
Sep 1, 2024, 09:02
Narjust Florez is one of the co-chairs at this year’s WCLC - Florez Lab
Blog
Sep 1, 2024, 09:00
Nishant Rajendra Tiwari: Ryan Nipp on Practical considerations in Academic Medicine at OU Health Stephenson Cancer Center
Insight
Sep 1, 2024, 08:30
Sacituzumab Govitecan in cisplatin-ineligible metastatic urothelial cancer after CPI
Insight
Sep 1, 2024, 08:24
Rahul Banerjee: Chronicle disparities in Relapsed or Refractory myeloma and why they matter
Insight
Sep 1, 2024, 08:23
Maria Carmen De Santis: Significance of HER2-Low in DCIS of the breast
Insight
Sep 1, 2024, 08:17
CAR T cells to discover and target vulnerabilities in invasive brain cancer
Insight
Sep 1, 2024, 08:12
Enhancing post - operative treatment for pancreatic ductal adenocarcinoma through AI
Insight
Sep 1, 2024, 08:01
Laura Rosenberger: Our latest PHYTR Lab’s research study